Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
JINIS Biopharmaceuticals
Wanju-gun, Jeollabuk-do, South Korea
- Ownership
- Private
- Development stage
- Other
01
Overview
JINIS Biopharmaceuticals is a South Korean biotechnology company focused on developing innovative therapies for metabolic diseases and oncology. The company leverages its proprietary drug discovery platform to identify novel small molecules and peptides targeting high-prevalence conditions such as obesity, type 2 diabetes, and nonalcoholic steatohepatitis (NASH). JINIS is particularly recognized for its research into GLP-1 receptor agonists and FGF21-based therapies, aiming to provide more effective and safer alternatives to current standards of care. With a strong foundation in metabolic research, the company is expanding its pipeline to include targeted cancer therapies and advanced drug delivery systems.
- Therapeutic areas
- EndocrinologyGastroenterologyOncology
- Modalities
- Small moleculePeptideBiologic
- Industry
- Biotech
Beyond the preview
Go deeper on JINIS Biopharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on JINIS Biopharmaceuticals.